Adamas Pharmaceuticals

FDA Action Alert: Adamas, Mallinckrodt and Merck
FDA Action Alert: Adamas, Mallinckrodt and Merck
BioSpace
FDA
Adamas Pharmaceuticals
Mallinckrodt
Merck
Gocovri
StrataGraft
Keytruda
triple negative breast cancer
Flag link:
Mark Your Calendar For February PDUFA Dates
Mark Your Calendar For February PDUFA Dates
Yahoo/Benzinga
FDA
Adamas Pharmaceuticals
Gocovri
Mallinckrodt
StrataGraft
Regeneron
evinacumab
Sanofi
Sarepta
TG Therapeutics
Flag link:
Adamas Announces Positive Results from Ph III Study of Gocovri in Parkinson’s Patients with Dyskinesia
Adamas Announces Positive Results from Ph III Study of Gocovri in Parkinson’s Patients with Dyskinesia
CP Wire
Adamas Pharmaceuticals
Gocovri
Parkinson's Disease
Flag link:
Adamas Announces Positive Results from Ph III Study of Gocovri in Parkinson’s Patients with Dyskinesia
Adamas Pharmaceuticals
Gocovri
Parkinson's Disease
Flag link:
Parkinson's Now a Hot Therapeutic Area: What's Up Lately?
Parkinson's Now a Hot Therapeutic Area: What's Up Lately?
Yahoo/Zacks.com
Parkinson's Disease
Novartis
Teva Pharmaceutial
UCB Pharma
MEDI1341
AstraZeneca
Takeda
PRX002
Prothena
Roche
Acorda
Inbrija
Adamas Pharmaceuticals
Gocovri
Flag link:
Adamas Parkinson's drug gains FDA approval
Adamas Parkinson's drug gains FDA approval
Biopharma Dive
Adamas Pharmaceuticals
Parkinson's Disease
FDA
Gocovri
Flag link:
Are These 2 Biotechs Diamonds in the Rough?
Are These 2 Biotechs Diamonds in the Rough?
Motley Fool
biotech
Amicus Therapeutics
Adamas Pharmaceuticals
ADS-5102
Galafold
Flag link:
These 15 Biotech Companies Could Be Takeover Targets
These 15 Biotech Companies Could Be Takeover Targets
Barron's
biotech
M&A
Alder Biopharmaceuticals
Biomarin
Coherus Biosciences
Intercept Pharma
Ultragenyx
Seattle Genetics
Adamas Pharmaceuticals
Alexion
Clovis Oncology
Corbus Pharmaceuticals
Incyte
Prothena
Puma Biotechnology
Tesaro
Versartis
Flag link:
Actavis, Adamas win FDA approval for Alzheimer's drug
Actavis, Adamas win FDA approval for Alzheimer's drug
Yahoo/Reuters
Actavis
Adamas Pharmaceuticals
FDA
Alzheimer's disease
dementia
Namzaric
Flag link:
IPO Preview: Adamas Pharmaceuticals
IPO Preview: Adamas Pharmaceuticals
Seeking Alpha
IPOs
Adamas Pharmaceuticals
Flag link:
Forest Labs and Adamas Pharma sign agreement to develop dementia treatment
Forest Labs and Adamas Pharma sign agreement to develop dementia treatment
Equities.com
Adamas Pharmaceuticals
Alzheimer's disease
Forest Labs
Flag link:
Forest Inks Alzheimer's Drug Deal
Forest Inks Alzheimer's Drug Deal
Yahoo/Zacks
Alzheimer's disease
Forest Labs
Namenda
Adamas Pharmaceuticals
Flag link: